Filing Details

Accession Number:
0001437749-25-020518
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-06-16 16:56:08
Reporting Period:
2025-06-12
Filing Date:
2025-06-16
Accepted Time:
2025-06-16 16:56:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1710340 Eton Pharmaceuticals Inc. ETON Pharmaceutical Preparations (2834) 371858472
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1968254 David Krempa C/O Eton Pharmaceuticals, Inc.
21925 W. Field Parkway, Suite 235
Deerpark IL 60010-7208
Chief Business Officer No Yes No No
Transaction Summary
Sold: 34,000 shares Avg. Price: $14.83 Total Value: $504,317.63
Number of Shares After Transactions: 612,646 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-06-12 16,977 $14.92 629,669 No 4 S Direct
Common Stock Disposition 2025-06-13 6,800 $14.77 622,869 No 4 S Direct
Common Stock Disposition 2025-06-16 10,223 $14.73 612,646 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The shares were sold in multiple trades at prices ranging from $14.77 to $14.98. The price reported above reflects the weighted average sales price.
  2. The shares were sold in multiple trades at prices ranging from $14.75 to $14.81. The price reported above reflects the weighted average sales price.
  3. The shares were sold in multiple trades at prices ranging from $14.50 to $14.79. The price reported above reflects the weighted average sales price.
  4. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.